Fundraising Fox

Euclises Pharmaceuticals

St. Louis, US · Founded 2011 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

CB
Charles BoltenDirector
RR
Rick RyanDirector
RD
Rajesh DevrajExecutive Officer, Director
JT
John TalleyDirector
RW
Robert W. KarrExecutive Officer, Director
EM
Eduardo MartinezDirector
RA
Robert A. BeardsleyDirector
RJ
Robert J. CalcaterraDirector
BW
Bobby W. Sandage, Jr.Executive Officer, Director

Investors · 2

iSelect FundSt. Louis · $250K – $2M
Atlas VenturereportedCambridge · $500K – $1Mvia Rajesh Devraj · board

Reported raises · per SEC filings

Form D private placements
▶$1.2MraisedDec 2016 · 5 investors · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • Charles A. BoltenDirector
  • John TalleyDirector
  • Robert J. CalcaterraDirector
  • Rajesh DevrajDirector
  • Rick RyanDirector
  • Robert A. BeardsleyDirector
  • Bobby W. Sandage, Jr.Executive Officer, Director
Offering amount
$2.7M
Amount sold
$1.2M
Minimum investment
$1
First sale
Nov 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$1.9MraisedOct 2015 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles BoltenDirector
  • Rick RyanDirector
  • Rajesh DevrajExecutive Officer, Director
  • John TalleyDirector
  • Robert W. KarrExecutive Officer, Director
  • Eduardo MartinezDirector
  • Robert A. BeardsleyDirector
  • Robert J. CalcaterraDirector
  • Bobby W. Sandage, Jr.Executive Officer, Director
Offering amount
$1.9M
Amount sold
$1.9M
First sale
Dec 2013
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.